IMDRF Issues Guidance On Personalized Medical Devices In Response To Tech Advancements

Given that it is now possible to produce individualized medical devices on a commercial rather than an artisanal scale, new measures are needed to keep up with the changing level of risk to patients.

Doctor woman sitting with male patient at the desk

How should the design of personalized medical devices be regulated when the breadth of variation makes it impossible to fully assess compliance? And how should the production system be regulated for such devices, given the large number of permutations that could occur?

This global conundrum is being tackled in a pre-market application guidance document from the International Medical Device Regulators Forum (IMDRF)...

Welcome to Medtech Insight

Create an account to read this article

More from International

As Medtech Tariffs Loom, AdvaMed Responds With Its Own Plan Emphasizing ‘Reciprocal’ Free Trade

 

The US Department of Commerce’s investigation into the national security impact of importing various medical equipment could lead to tariffs on many products. Device industry responds by emphasizing the robustness of domestic production, but also the rigidity of supply and reimbursement agreements.

Persistence Pays Off: New International Clinical Evaluation Standard Is Finally On Horizon

 

Clinical evaluation and standards expert Danielle Giroud celebrates progress on the document and looks at what it means internationally and for the EU.

Global Medtech Guidance Tracker: September 2025

 
• By 

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Over 40 documents have been posted on the tracker since its last update.

Going Global In Medtech? LSX Panel Of Medtech Veterans Share Lessons From Front Lines

 
• By 

At LSX World Congress USA, medtech executives shared lessons on global expansion, from regulatory pitfalls to cultural nuances and funding gaps. Their message: Prepare early, secure capital, and choose partners wisely.

More from Geography

Medicare’s TCET Pathway Wins Acclaim From Early Users, Even As ‘Messy Middle’ Persists

 

Some of the first manufacturers to receive Medicare coverage for their breakthrough devices through the Transitional Coverage for Emerging Technologies pathway praise CMS’ engagement and timelines in the process, despite some challenges around post-launch data collection.

German Medtechs Choking Under EU Compliance And Reporting Obligations Tout Mutual Recognition

 
• By 

Industry survey points to ongoing low revenues rise and weaker profit levels for half of BVMed industry association members in 2025, as German manufacturers raise stakes on global harmonization.

Fixing The Fractures: New Aspirations For EU Medtech Regulatory Progress

 

A pioneering initiative, Edvance MedTech, is being launched by leading experts in medical technology regulation which aims get to the heart of what is needed to improve the way EU rules are not only applied but also decided.